Compile Data Set for Download or QSAR

Found 2287 hits with Last Name = 'ferrara' and Initial = 'm'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Genome polyprotein (Hepacivirus C)	BDBM50485494 (CHEMBL2063089) Show SMILES [H][C@@]12C[C@@]1([H])OC(=O)N[C@H](C(=O)N1C[C@@]([H])(C[C@H]1C(=O)N[C@@]1(C[C@@]1([H])C=C)C(=O)NS(=O)(=O)C1CC1)Oc1cc3cc(OC)ccc3nc1CCCCC2)C(C)(C)C |r| Show InChI InChI=1S/C39H51N5O9S/c1-6-24-20-39(24,36(47)43-54(49,50)27-13-14-27)42-34(45)30-19-26-21-44(30)35(46)33(38(2,3)4)41-37(48)53-31-17-22(31)10-8-7-9-11-29-32(52-26)18-23-16-25(51-5)12-15-28(23)40-29/h6,12,15-16,18,22,24,26-27,30-31,33H,1,7-11,13-14,17,19-21H2,2-5H3,(H,41,48)(H,42,45)(H,43,47)/t22-,24-,26-,30+,31-,33-,39-/m1/s1	PDB Reactome pathway KEGG UniProtKB/TrEMBL DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	0.0500	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Merck Research Laboratories Curated by ChEMBL					Assay Description Inhibition of Hepatitis C virus (isolate BK) genotype 1b NS3/4a protease D168V mutant expressed in Escherichia coli by time-resolved fluorescence ana...				ACS Med Chem Lett 3: 332-6 (2012) Article DOI: 10.1021/ml300017p BindingDB Entry DOI: 10.7270/Q2KH0R6V
					More data for this Ligand-Target Pair
Genome polyprotein (Hepacivirus C)	BDBM50485491 (CHEMBL2063088) Show SMILES [H][C@@]12C[C@H](N(C1)C(=O)[C@@H](NC(=O)O[C@]1([H])CCC[C@@]1([H])CCCCCc1nc3ccc(OC)cc3cc1O2)C(C)(C)C)C(=O)N[C@@]1(C[C@H]1C=C)C(=O)NS(=O)(=O)C1CC1 |r| Show InChI InChI=1S/C41H55N5O9S/c1-6-26-22-41(26,38(49)45-56(51,52)29-16-17-29)44-36(47)32-21-28-23-46(32)37(48)35(40(2,3)4)43-39(50)55-33-14-10-12-24(33)11-8-7-9-13-31-34(54-28)20-25-19-27(53-5)15-18-30(25)42-31/h6,15,18-20,24,26,28-29,32-33,35H,1,7-14,16-17,21-23H2,2-5H3,(H,43,50)(H,44,47)(H,45,49)/t24-,26-,28-,32+,33-,35-,41-/m1/s1	PDB Reactome pathway KEGG UniProtKB/TrEMBL DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	0.0600	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Merck Research Laboratories Curated by ChEMBL					Assay Description Inhibition of Hepatitis C virus (isolate BK) genotype 1b NS3/4a protease D168V mutant expressed in Escherichia coli by time-resolved fluorescence ana...				ACS Med Chem Lett 3: 332-6 (2012) Article DOI: 10.1021/ml300017p BindingDB Entry DOI: 10.7270/Q2KH0R6V
					More data for this Ligand-Target Pair
Genome polyprotein (Hepacivirus C)	BDBM50485492 (Grazoprevir | Grazoprevir monohydrate | MK-5172 | ...) Show SMILES [H][C@@]12C[C@@]1([H])OC(=O)N[C@H](C(=O)N1C[C@@]([H])(C[C@H]1C(=O)N[C@@]1(C[C@H]1C=C)C(=O)NS(=O)(=O)C1CC1)Oc1nc3cc(OC)ccc3nc1CCCCC2)C(C)(C)C |r| Show InChI InChI=1S/C38H50N6O9S/c1-6-22-19-38(22,35(47)43-54(49,50)25-13-14-25)42-32(45)29-18-24-20-44(29)34(46)31(37(2,3)4)41-36(48)53-30-16-21(30)10-8-7-9-11-27-33(52-24)40-28-17-23(51-5)12-15-26(28)39-27/h6,12,15,17,21-22,24-25,29-31H,1,7-11,13-14,16,18-20H2,2-5H3,(H,41,48)(H,42,45)(H,43,47)/t21-,22-,24-,29+,30-,31-,38-/m1/s1	PDB Reactome pathway KEGG UniProtKB/TrEMBL DrugBank GoogleScholar AffyNet	Purchase MCE PC cid PC sid PDB UniChem	PDB Article PubMed	0.140	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Merck Research Laboratories Curated by ChEMBL					Assay Description Inhibition of Hepatitis C virus (isolate BK) genotype 1b NS3/4a protease D168V mutant expressed in Escherichia coli by time-resolved fluorescence ana...				ACS Med Chem Lett 3: 332-6 (2012) Article DOI: 10.1021/ml300017p BindingDB Entry DOI: 10.7270/Q2KH0R6V
					More data for this Ligand-Target Pair				3D Structure (crystal)
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311944 (US10166214, Example 80 | US10675268, Example 80 | ...) Show SMILES Cc1ncc(c2ccccc12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12 |r| Show InChI InChI=1S/C19H23N3O/c1-11-12-6-4-5-7-13(12)16(10-21-11)19(2,3)22-18(23)17-14-8-20-9-15(14)17/h4-7,10,14-15,17,20H,8-9H2,1-3H3,(H,22,23)/t14-,15+,17+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	1.20	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description Receptor binding assays refer to a technique in which labeled receptor ligands are used to detect binding to a receptor. In competition experiments t...				US Patent US9789082 (2017) BindingDB Entry DOI: 10.7270/Q2CN760Q
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311944 (US10166214, Example 80 | US10675268, Example 80 | ...) Show SMILES Cc1ncc(c2ccccc12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12 |r| Show InChI InChI=1S/C19H23N3O/c1-11-12-6-4-5-7-13(12)16(10-21-11)19(2,3)22-18(23)17-14-8-20-9-15(14)17/h4-7,10,14-15,17,20H,8-9H2,1-3H3,(H,22,23)/t14-,15+,17+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	1.20	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description Receptor binding assays refer to a technique in which labeled receptor ligands are used to detect binding to a receptor. In competition experiments t...				US Patent US10675268 (2020) BindingDB Entry DOI: 10.7270/Q21C20XK
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311944 (US10166214, Example 80 | US10675268, Example 80 | ...) Show SMILES Cc1ncc(c2ccccc12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12 |r| Show InChI InChI=1S/C19H23N3O/c1-11-12-6-4-5-7-13(12)16(10-21-11)19(2,3)22-18(23)17-14-8-20-9-15(14)17/h4-7,10,14-15,17,20H,8-9H2,1-3H3,(H,22,23)/t14-,15+,17+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	1.20	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...				US Patent US10166214 (2019) BindingDB Entry DOI: 10.7270/Q2D50Q16
					More data for this Ligand-Target Pair
Genome polyprotein (Hepacivirus C)	BDBM50485491 (CHEMBL2063088) Show SMILES [H][C@@]12C[C@H](N(C1)C(=O)[C@@H](NC(=O)O[C@]1([H])CCC[C@@]1([H])CCCCCc1nc3ccc(OC)cc3cc1O2)C(C)(C)C)C(=O)N[C@@]1(C[C@H]1C=C)C(=O)NS(=O)(=O)C1CC1 |r| Show InChI InChI=1S/C41H55N5O9S/c1-6-26-22-41(26,38(49)45-56(51,52)29-16-17-29)44-36(47)32-21-28-23-46(32)37(48)35(40(2,3)4)43-39(50)55-33-14-10-12-24(33)11-8-7-9-13-31-34(54-28)20-25-19-27(53-5)15-18-30(25)42-31/h6,15,18-20,24,26,28-29,32-33,35H,1,7-14,16-17,21-23H2,2-5H3,(H,43,50)(H,44,47)(H,45,49)/t24-,26-,28-,32+,33-,35-,41-/m1/s1	PDB Reactome pathway KEGG UniProtKB/TrEMBL DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	2.40	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Merck Research Laboratories Curated by ChEMBL					Assay Description Inhibition of Hepatitis C virus (isolate BK) genotype 1b NS3/4a protease A156T mutant expressed in Escherichia coli by time-resolved fluorescence ana...				ACS Med Chem Lett 3: 332-6 (2012) Article DOI: 10.1021/ml300017p BindingDB Entry DOI: 10.7270/Q2KH0R6V
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311888 (US10166214, Example 24 | US10675268, Example 24 | ...) Show SMILES CC(C)(NC(=O)[C@@H]1[C@H]2CNC[C@@H]12)c1nccc2ccccc12 |r| Show InChI InChI=1S/C18H21N3O/c1-18(2,21-17(22)15-13-9-19-10-14(13)15)16-12-6-4-3-5-11(12)7-8-20-16/h3-8,13-15,19H,9-10H2,1-2H3,(H,21,22)/t13-,14+,15+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	2.90	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...				US Patent US10166214 (2019) BindingDB Entry DOI: 10.7270/Q2D50Q16
					More data for this Ligand-Target Pair
Genome polyprotein (Hepacivirus C)	BDBM50485494 (CHEMBL2063089) Show SMILES [H][C@@]12C[C@@]1([H])OC(=O)N[C@H](C(=O)N1C[C@@]([H])(C[C@H]1C(=O)N[C@@]1(C[C@@]1([H])C=C)C(=O)NS(=O)(=O)C1CC1)Oc1cc3cc(OC)ccc3nc1CCCCC2)C(C)(C)C |r| Show InChI InChI=1S/C39H51N5O9S/c1-6-24-20-39(24,36(47)43-54(49,50)27-13-14-27)42-34(45)30-19-26-21-44(30)35(46)33(38(2,3)4)41-37(48)53-31-17-22(31)10-8-7-9-11-29-32(52-26)18-23-16-25(51-5)12-15-28(23)40-29/h6,12,15-16,18,22,24,26-27,30-31,33H,1,7-11,13-14,17,19-21H2,2-5H3,(H,41,48)(H,42,45)(H,43,47)/t22-,24-,26-,30+,31-,33-,39-/m1/s1	PDB Reactome pathway KEGG UniProtKB/TrEMBL DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	2.90	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Merck Research Laboratories Curated by ChEMBL					Assay Description Inhibition of Hepatitis C virus (isolate BK) genotype 1b NS3/4a protease A156T mutant expressed in Escherichia coli by time-resolved fluorescence ana...				ACS Med Chem Lett 3: 332-6 (2012) Article DOI: 10.1021/ml300017p BindingDB Entry DOI: 10.7270/Q2KH0R6V
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311888 (US10166214, Example 24 | US10675268, Example 24 | ...) Show SMILES CC(C)(NC(=O)[C@@H]1[C@H]2CNC[C@@H]12)c1nccc2ccccc12 |r| Show InChI InChI=1S/C18H21N3O/c1-18(2,21-17(22)15-13-9-19-10-14(13)15)16-12-6-4-3-5-11(12)7-8-20-16/h3-8,13-15,19H,9-10H2,1-2H3,(H,21,22)/t13-,14+,15+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	2.90	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description Receptor binding assays refer to a technique in which labeled receptor ligands are used to detect binding to a receptor. In competition experiments t...				US Patent US9789082 (2017) BindingDB Entry DOI: 10.7270/Q2CN760Q
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311888 (US10166214, Example 24 | US10675268, Example 24 | ...) Show SMILES CC(C)(NC(=O)[C@@H]1[C@H]2CNC[C@@H]12)c1nccc2ccccc12 |r| Show InChI InChI=1S/C18H21N3O/c1-18(2,21-17(22)15-13-9-19-10-14(13)15)16-12-6-4-3-5-11(12)7-8-20-16/h3-8,13-15,19H,9-10H2,1-2H3,(H,21,22)/t13-,14+,15+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	2.90	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description Receptor binding assays refer to a technique in which labeled receptor ligands are used to detect binding to a receptor. In competition experiments t...				US Patent US10675268 (2020) BindingDB Entry DOI: 10.7270/Q21C20XK
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311990 (US10166214, Example 126 | US10675268, Example 126 ...) Show SMILES Cc1cccn2c(ncc12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12 |r| Show InChI InChI=1S/C17H22N4O/c1-10-5-4-6-21-13(10)9-19-16(21)17(2,3)20-15(22)14-11-7-18-8-12(11)14/h4-6,9,11-12,14,18H,7-8H2,1-3H3,(H,20,22)/t11-,12+,14+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...				US Patent US10166214 (2019) BindingDB Entry DOI: 10.7270/Q2D50Q16
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311990 (US10166214, Example 126 | US10675268, Example 126 ...) Show SMILES Cc1cccn2c(ncc12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12 |r| Show InChI InChI=1S/C17H22N4O/c1-10-5-4-6-21-13(10)9-19-16(21)17(2,3)20-15(22)14-11-7-18-8-12(11)14/h4-6,9,11-12,14,18H,7-8H2,1-3H3,(H,20,22)/t11-,12+,14+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description Receptor binding assays refer to a technique in which labeled receptor ligands are used to detect binding to a receptor. In competition experiments t...				US Patent US9789082 (2017) BindingDB Entry DOI: 10.7270/Q2CN760Q
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311990 (US10166214, Example 126 | US10675268, Example 126 ...) Show SMILES Cc1cccn2c(ncc12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12 |r| Show InChI InChI=1S/C17H22N4O/c1-10-5-4-6-21-13(10)9-19-16(21)17(2,3)20-15(22)14-11-7-18-8-12(11)14/h4-6,9,11-12,14,18H,7-8H2,1-3H3,(H,20,22)/t11-,12+,14+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description Receptor binding assays refer to a technique in which labeled receptor ligands are used to detect binding to a receptor. In competition experiments t...				US Patent US10675268 (2020) BindingDB Entry DOI: 10.7270/Q21C20XK
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311971 (US10166214, Example 107 | US10675268, Example 107 ...) Show SMILES Cc1cccc2c(nn(C)c12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12 |r| Show InChI InChI=1S/C18H24N4O/c1-10-6-5-7-11-15(10)22(4)21-16(11)18(2,3)20-17(23)14-12-8-19-9-13(12)14/h5-7,12-14,19H,8-9H2,1-4H3,(H,20,23)/t12-,13+,14+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	Purchase MCE PC cid PC sid UniChem	US Patent	3.40	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description Receptor binding assays refer to a technique in which labeled receptor ligands are used to detect binding to a receptor. In competition experiments t...				US Patent US10675268 (2020) BindingDB Entry DOI: 10.7270/Q21C20XK
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311971 (US10166214, Example 107 | US10675268, Example 107 ...) Show SMILES Cc1cccc2c(nn(C)c12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12 |r| Show InChI InChI=1S/C18H24N4O/c1-10-6-5-7-11-15(10)22(4)21-16(11)18(2,3)20-17(23)14-12-8-19-9-13(12)14/h5-7,12-14,19H,8-9H2,1-4H3,(H,20,23)/t12-,13+,14+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	Purchase MCE PC cid PC sid UniChem	US Patent	3.40	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description Receptor binding assays refer to a technique in which labeled receptor ligands are used to detect binding to a receptor. In competition experiments t...				US Patent US9789082 (2017) BindingDB Entry DOI: 10.7270/Q2CN760Q
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311971 (US10166214, Example 107 | US10675268, Example 107 ...) Show SMILES Cc1cccc2c(nn(C)c12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12 |r| Show InChI InChI=1S/C18H24N4O/c1-10-6-5-7-11-15(10)22(4)21-16(11)18(2,3)20-17(23)14-12-8-19-9-13(12)14/h5-7,12-14,19H,8-9H2,1-4H3,(H,20,23)/t12-,13+,14+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	Purchase MCE PC cid PC sid UniChem	US Patent	3.40	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...				US Patent US10166214 (2019) BindingDB Entry DOI: 10.7270/Q2D50Q16
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311957 (US10166214, Example 93 | US10675268, Example 93 | ...) Show SMILES Cc1cccc2c(n[nH]c12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12 |r| Show InChI	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	3.60	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description Receptor binding assays refer to a technique in which labeled receptor ligands are used to detect binding to a receptor. In competition experiments t...				US Patent US10675268 (2020) BindingDB Entry DOI: 10.7270/Q21C20XK
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311957 (US10166214, Example 93 | US10675268, Example 93 | ...) Show SMILES Cc1cccc2c(n[nH]c12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12 |r| Show InChI	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	3.60	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description Receptor binding assays refer to a technique in which labeled receptor ligands are used to detect binding to a receptor. In competition experiments t...				US Patent US9789082 (2017) BindingDB Entry DOI: 10.7270/Q2CN760Q
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311957 (US10166214, Example 93 | US10675268, Example 93 | ...) Show SMILES Cc1cccc2c(n[nH]c12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12 |r| Show InChI	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	3.60	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...				US Patent US10166214 (2019) BindingDB Entry DOI: 10.7270/Q2D50Q16
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM50081058 (CHEMBL3421842 | US10166214, Example 22 | US1067526...) Show SMILES [H][C@@]12CNC[C@]1([H])[C@H]2C(=O)NC(C)(C)c1nc(C)cc2ccccc12 |r| Show InChI InChI=1S/C19H23N3O/c1-11-8-12-6-4-5-7-13(12)17(21-11)19(2,3)22-18(23)16-14-9-20-10-15(14)16/h4-8,14-16,20H,9-10H2,1-3H3,(H,22,23)/t14-,15+,16+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	US Patent	3.70	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description Receptor binding assays refer to a technique in which labeled receptor ligands are used to detect binding to a receptor. In competition experiments t...				US Patent US10675268 (2020) BindingDB Entry DOI: 10.7270/Q21C20XK
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM50081058 (CHEMBL3421842 | US10166214, Example 22 | US1067526...) Show SMILES [H][C@@]12CNC[C@]1([H])[C@H]2C(=O)NC(C)(C)c1nc(C)cc2ccccc12 |r| Show InChI InChI=1S/C19H23N3O/c1-11-8-12-6-4-5-7-13(12)17(21-11)19(2,3)22-18(23)16-14-9-20-10-15(14)16/h4-8,14-16,20H,9-10H2,1-3H3,(H,22,23)/t14-,15+,16+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	US Patent	3.70	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...				US Patent US10166214 (2019) BindingDB Entry DOI: 10.7270/Q2D50Q16
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM50081058 (CHEMBL3421842 | US10166214, Example 22 | US1067526...) Show SMILES [H][C@@]12CNC[C@]1([H])[C@H]2C(=O)NC(C)(C)c1nc(C)cc2ccccc12 |r| Show InChI InChI=1S/C19H23N3O/c1-11-8-12-6-4-5-7-13(12)17(21-11)19(2,3)22-18(23)16-14-9-20-10-15(14)16/h4-8,14-16,20H,9-10H2,1-3H3,(H,22,23)/t14-,15+,16+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	US Patent	3.70	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description Receptor binding assays refer to a technique in which labeled receptor ligands are used to detect binding to a receptor. In competition experiments t...				US Patent US9789082 (2017) BindingDB Entry DOI: 10.7270/Q2CN760Q
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM50081055 (CHEMBL3421843 | US10166214, Example 49 | US1067526...) Show SMILES [H][C@@]12CNC[C@]1([H])[C@H]2C(=O)NC(C)(C)c1nn(C)c2ccccc12 |r| Show InChI InChI=1S/C17H22N4O/c1-17(2,19-16(22)14-11-8-18-9-12(11)14)15-10-6-4-5-7-13(10)21(3)20-15/h4-7,11-12,14,18H,8-9H2,1-3H3,(H,19,22)/t11-,12+,14+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	Purchase CHEMBL PC cid PC sid UniChem Similars	US Patent	4.5	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description Receptor binding assays refer to a technique in which labeled receptor ligands are used to detect binding to a receptor. In competition experiments t...				US Patent US9789082 (2017) BindingDB Entry DOI: 10.7270/Q2CN760Q
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM50081055 (CHEMBL3421843 | US10166214, Example 49 | US1067526...) Show SMILES [H][C@@]12CNC[C@]1([H])[C@H]2C(=O)NC(C)(C)c1nn(C)c2ccccc12 |r| Show InChI InChI=1S/C17H22N4O/c1-17(2,19-16(22)14-11-8-18-9-12(11)14)15-10-6-4-5-7-13(10)21(3)20-15/h4-7,11-12,14,18H,8-9H2,1-3H3,(H,19,22)/t11-,12+,14+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	Purchase CHEMBL PC cid PC sid UniChem Similars	US Patent	4.5	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...				US Patent US10166214 (2019) BindingDB Entry DOI: 10.7270/Q2D50Q16
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM50081055 (CHEMBL3421843 | US10166214, Example 49 | US1067526...) Show SMILES [H][C@@]12CNC[C@]1([H])[C@H]2C(=O)NC(C)(C)c1nn(C)c2ccccc12 |r| Show InChI InChI=1S/C17H22N4O/c1-17(2,19-16(22)14-11-8-18-9-12(11)14)15-10-6-4-5-7-13(10)21(3)20-15/h4-7,11-12,14,18H,8-9H2,1-3H3,(H,19,22)/t11-,12+,14+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	Purchase CHEMBL PC cid PC sid UniChem Similars	US Patent	4.5	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description Receptor binding assays refer to a technique in which labeled receptor ligands are used to detect binding to a receptor. In competition experiments t...				US Patent US10675268 (2020) BindingDB Entry DOI: 10.7270/Q21C20XK
					More data for this Ligand-Target Pair
Genome polyprotein (Hepacivirus C)	BDBM50485492 (Grazoprevir | Grazoprevir monohydrate | MK-5172 | ...) Show SMILES [H][C@@]12C[C@@]1([H])OC(=O)N[C@H](C(=O)N1C[C@@]([H])(C[C@H]1C(=O)N[C@@]1(C[C@H]1C=C)C(=O)NS(=O)(=O)C1CC1)Oc1nc3cc(OC)ccc3nc1CCCCC2)C(C)(C)C |r| Show InChI InChI=1S/C38H50N6O9S/c1-6-22-19-38(22,35(47)43-54(49,50)25-13-14-25)42-32(45)29-18-24-20-44(29)34(46)31(37(2,3)4)41-36(48)53-30-16-21(30)10-8-7-9-11-27-33(52-24)40-28-17-23(51-5)12-15-26(28)39-27/h6,12,15,17,21-22,24-25,29-31H,1,7-11,13-14,16,18-20H2,2-5H3,(H,41,48)(H,42,45)(H,43,47)/t21-,22-,24-,29+,30-,31-,38-/m1/s1	PDB Reactome pathway KEGG UniProtKB/TrEMBL DrugBank GoogleScholar AffyNet	Purchase MCE PC cid PC sid PDB UniChem	PDB Article PubMed	5.30	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Merck Research Laboratories Curated by ChEMBL					Assay Description Inhibition of Hepatitis C virus (isolate BK) genotype 1b NS3/4a protease A156T mutant expressed in Escherichia coli by time-resolved fluorescence ana...				ACS Med Chem Lett 3: 332-6 (2012) Article DOI: 10.1021/ml300017p BindingDB Entry DOI: 10.7270/Q2KH0R6V
					More data for this Ligand-Target Pair				3D Structure (crystal)
Genome polyprotein (Hepacivirus C)	BDBM50485494 (CHEMBL2063089) Show SMILES [H][C@@]12C[C@@]1([H])OC(=O)N[C@H](C(=O)N1C[C@@]([H])(C[C@H]1C(=O)N[C@@]1(C[C@@]1([H])C=C)C(=O)NS(=O)(=O)C1CC1)Oc1cc3cc(OC)ccc3nc1CCCCC2)C(C)(C)C |r| Show InChI InChI=1S/C39H51N5O9S/c1-6-24-20-39(24,36(47)43-54(49,50)27-13-14-27)42-34(45)30-19-26-21-44(30)35(46)33(38(2,3)4)41-37(48)53-31-17-22(31)10-8-7-9-11-29-32(52-26)18-23-16-25(51-5)12-15-28(23)40-29/h6,12,15-16,18,22,24,26-27,30-31,33H,1,7-11,13-14,17,19-21H2,2-5H3,(H,41,48)(H,42,45)(H,43,47)/t22-,24-,26-,30+,31-,33-,39-/m1/s1	PDB Reactome pathway KEGG UniProtKB/TrEMBL DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	5.70	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Merck Research Laboratories Curated by ChEMBL					Assay Description Inhibition of Hepatitis C virus (isolate BK) genotype 1b NS3/4a protease A156V mutant expressed in Escherichia coli by time-resolved fluorescence ana...				ACS Med Chem Lett 3: 332-6 (2012) Article DOI: 10.1021/ml300017p BindingDB Entry DOI: 10.7270/Q2KH0R6V
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311992 (US10166214, Example 128 | US10675268, Example 128 ...) Show SMILES Cc1cccn2c(nc(C3CC3)c12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12 |r| Show InChI InChI=1S/C20H26N4O/c1-11-5-4-8-24-17(11)16(12-6-7-12)22-19(24)20(2,3)23-18(25)15-13-9-21-10-14(13)15/h4-5,8,12-15,21H,6-7,9-10H2,1-3H3,(H,23,25)/t13-,14+,15+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	7.60	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description Receptor binding assays refer to a technique in which labeled receptor ligands are used to detect binding to a receptor. In competition experiments t...				US Patent US10675268 (2020) BindingDB Entry DOI: 10.7270/Q21C20XK
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311992 (US10166214, Example 128 | US10675268, Example 128 ...) Show SMILES Cc1cccn2c(nc(C3CC3)c12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12 |r| Show InChI InChI=1S/C20H26N4O/c1-11-5-4-8-24-17(11)16(12-6-7-12)22-19(24)20(2,3)23-18(25)15-13-9-21-10-14(13)15/h4-5,8,12-15,21H,6-7,9-10H2,1-3H3,(H,23,25)/t13-,14+,15+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	7.60	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description Receptor binding assays refer to a technique in which labeled receptor ligands are used to detect binding to a receptor. In competition experiments t...				US Patent US9789082 (2017) BindingDB Entry DOI: 10.7270/Q2CN760Q
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311992 (US10166214, Example 128 | US10675268, Example 128 ...) Show SMILES Cc1cccn2c(nc(C3CC3)c12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12 |r| Show InChI InChI=1S/C20H26N4O/c1-11-5-4-8-24-17(11)16(12-6-7-12)22-19(24)20(2,3)23-18(25)15-13-9-21-10-14(13)15/h4-5,8,12-15,21H,6-7,9-10H2,1-3H3,(H,23,25)/t13-,14+,15+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	7.60	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...				US Patent US10166214 (2019) BindingDB Entry DOI: 10.7270/Q2D50Q16
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311885 (US10166214, Example 21 | US10675268, Example 21 | ...) Show SMILES CC(C)(NC(=O)[C@@H]1[C@H]2CNC[C@@H]12)c1ccnc2ccccc12 |r| Show InChI InChI=1S/C18H21N3O/c1-18(2,21-17(22)16-12-9-19-10-13(12)16)14-7-8-20-15-6-4-3-5-11(14)15/h3-8,12-13,16,19H,9-10H2,1-2H3,(H,21,22)/t12-,13+,16+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	10.8	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description Receptor binding assays refer to a technique in which labeled receptor ligands are used to detect binding to a receptor. In competition experiments t...				US Patent US9789082 (2017) BindingDB Entry DOI: 10.7270/Q2CN760Q
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311885 (US10166214, Example 21 | US10675268, Example 21 | ...) Show SMILES CC(C)(NC(=O)[C@@H]1[C@H]2CNC[C@@H]12)c1ccnc2ccccc12 |r| Show InChI InChI=1S/C18H21N3O/c1-18(2,21-17(22)16-12-9-19-10-13(12)16)14-7-8-20-15-6-4-3-5-11(14)15/h3-8,12-13,16,19H,9-10H2,1-2H3,(H,21,22)/t12-,13+,16+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	10.8	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...				US Patent US10166214 (2019) BindingDB Entry DOI: 10.7270/Q2D50Q16
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311885 (US10166214, Example 21 | US10675268, Example 21 | ...) Show SMILES CC(C)(NC(=O)[C@@H]1[C@H]2CNC[C@@H]12)c1ccnc2ccccc12 |r| Show InChI InChI=1S/C18H21N3O/c1-18(2,21-17(22)16-12-9-19-10-13(12)16)14-7-8-20-15-6-4-3-5-11(14)15/h3-8,12-13,16,19H,9-10H2,1-2H3,(H,21,22)/t12-,13+,16+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	10.8	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description Receptor binding assays refer to a technique in which labeled receptor ligands are used to detect binding to a receptor. In competition experiments t...				US Patent US10675268 (2020) BindingDB Entry DOI: 10.7270/Q21C20XK
					More data for this Ligand-Target Pair
Genome polyprotein (Hepacivirus C)	BDBM50485491 (CHEMBL2063088) Show SMILES [H][C@@]12C[C@H](N(C1)C(=O)[C@@H](NC(=O)O[C@]1([H])CCC[C@@]1([H])CCCCCc1nc3ccc(OC)cc3cc1O2)C(C)(C)C)C(=O)N[C@@]1(C[C@H]1C=C)C(=O)NS(=O)(=O)C1CC1 |r| Show InChI InChI=1S/C41H55N5O9S/c1-6-26-22-41(26,38(49)45-56(51,52)29-16-17-29)44-36(47)32-21-28-23-46(32)37(48)35(40(2,3)4)43-39(50)55-33-14-10-12-24(33)11-8-7-9-13-31-34(54-28)20-25-19-27(53-5)15-18-30(25)42-31/h6,15,18-20,24,26,28-29,32-33,35H,1,7-14,16-17,21-23H2,2-5H3,(H,43,50)(H,44,47)(H,45,49)/t24-,26-,28-,32+,33-,35-,41-/m1/s1	PDB Reactome pathway KEGG UniProtKB/TrEMBL DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	11	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Merck Research Laboratories Curated by ChEMBL					Assay Description Inhibition of Hepatitis C virus (isolate BK) genotype 1b NS3/4a protease A156V mutant expressed in Escherichia coli by time-resolved fluorescence ana...				ACS Med Chem Lett 3: 332-6 (2012) Article DOI: 10.1021/ml300017p BindingDB Entry DOI: 10.7270/Q2KH0R6V
					More data for this Ligand-Target Pair
Genome polyprotein (Hepacivirus C)	BDBM50485492 (Grazoprevir | Grazoprevir monohydrate | MK-5172 | ...) Show SMILES [H][C@@]12C[C@@]1([H])OC(=O)N[C@H](C(=O)N1C[C@@]([H])(C[C@H]1C(=O)N[C@@]1(C[C@H]1C=C)C(=O)NS(=O)(=O)C1CC1)Oc1nc3cc(OC)ccc3nc1CCCCC2)C(C)(C)C |r| Show InChI InChI=1S/C38H50N6O9S/c1-6-22-19-38(22,35(47)43-54(49,50)25-13-14-25)42-32(45)29-18-24-20-44(29)34(46)31(37(2,3)4)41-36(48)53-30-16-21(30)10-8-7-9-11-27-33(52-24)40-28-17-23(51-5)12-15-26(28)39-27/h6,12,15,17,21-22,24-25,29-31H,1,7-11,13-14,16,18-20H2,2-5H3,(H,41,48)(H,42,45)(H,43,47)/t21-,22-,24-,29+,30-,31-,38-/m1/s1	PDB Reactome pathway KEGG UniProtKB/TrEMBL DrugBank GoogleScholar AffyNet	Purchase MCE PC cid PC sid PDB UniChem	PDB Article PubMed	12	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Merck Research Laboratories Curated by ChEMBL					Assay Description Inhibition of Hepatitis C virus (isolate BK) genotype 1b NS3/4a protease A156V mutant expressed in Escherichia coli by time-resolved fluorescence ana...				ACS Med Chem Lett 3: 332-6 (2012) Article DOI: 10.1021/ml300017p BindingDB Entry DOI: 10.7270/Q2KH0R6V
					More data for this Ligand-Target Pair				3D Structure (crystal)
Genome polyprotein (Hepacivirus C)	BDBM50485490 (CHEMBL2063087) Show SMILES [H][C@@]12C[C@H](N(C1)C(=O)[C@@H](NC(=O)OCC(C)(C)CCCCCc1nc3ccc(OC)cc3cc1O2)C1CCCCC1)C(=O)N[C@@]1(C[C@H]1C=C)C(=O)NS(=O)(=O)C1CC1 |r| Show InChI InChI=1S/C42H57N5O9S/c1-5-28-23-42(28,39(50)46-57(52,53)31-16-17-31)45-37(48)34-22-30-24-47(34)38(49)36(26-12-8-6-9-13-26)44-40(51)55-25-41(2,3)19-11-7-10-14-33-35(56-30)21-27-20-29(54-4)15-18-32(27)43-33/h5,15,18,20-21,26,28,30-31,34,36H,1,6-14,16-17,19,22-25H2,2-4H3,(H,44,51)(H,45,48)(H,46,50)/t28-,30-,34+,36+,42-/m1/s1	PDB Reactome pathway KEGG UniProtKB/TrEMBL DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	12	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Merck Research Laboratories Curated by ChEMBL					Assay Description Inhibition of Hepatitis C virus (isolate BK) genotype 1b NS3/4a protease A156T mutant expressed in Escherichia coli by time-resolved fluorescence ana...				ACS Med Chem Lett 3: 332-6 (2012) Article DOI: 10.1021/ml300017p BindingDB Entry DOI: 10.7270/Q2KH0R6V
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311958 (US10166214, Example 94 | US10675268, Example 94 | ...) Show SMILES CC(C)(NC(=O)[C@@H]1[C@H]2CNC[C@@H]12)c1n[nH]c2ccccc12 |r| Show InChI	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	15.9	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description Receptor binding assays refer to a technique in which labeled receptor ligands are used to detect binding to a receptor. In competition experiments t...				US Patent US9789082 (2017) BindingDB Entry DOI: 10.7270/Q2CN760Q
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311958 (US10166214, Example 94 | US10675268, Example 94 | ...) Show SMILES CC(C)(NC(=O)[C@@H]1[C@H]2CNC[C@@H]12)c1n[nH]c2ccccc12 |r| Show InChI	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	15.9	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...				US Patent US10166214 (2019) BindingDB Entry DOI: 10.7270/Q2D50Q16
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311958 (US10166214, Example 94 | US10675268, Example 94 | ...) Show SMILES CC(C)(NC(=O)[C@@H]1[C@H]2CNC[C@@H]12)c1n[nH]c2ccccc12 |r| Show InChI	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	15.9	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description Receptor binding assays refer to a technique in which labeled receptor ligands are used to detect binding to a receptor. In competition experiments t...				US Patent US10675268 (2020) BindingDB Entry DOI: 10.7270/Q21C20XK
					More data for this Ligand-Target Pair
Genome polyprotein (Hepacivirus C)	BDBM50485495 (CHEMBL2063085) Show SMILES [H][C@@]12C[C@H](N(C1)C(=O)[C@@H](NC(=O)OCC(C)(C)CCC\C=C\c1nc3ccccc3cc1O2)C1CCCCC1)C(=O)N[C@@]1(C[C@H]1C=C)C(=O)NS(=O)(=O)C1CC1 |r,t:21| Show InChI InChI=1S/C41H53N5O8S/c1-4-28-23-41(28,38(49)45-55(51,52)30-18-19-30)44-36(47)33-22-29-24-46(33)37(48)35(26-13-7-5-8-14-26)43-39(50)53-25-40(2,3)20-12-6-9-17-32-34(54-29)21-27-15-10-11-16-31(27)42-32/h4,9-11,15-17,21,26,28-30,33,35H,1,5-8,12-14,18-20,22-25H2,2-3H3,(H,43,50)(H,44,47)(H,45,49)/b17-9+/t28-,29-,33+,35+,41-/m1/s1	PDB Reactome pathway KEGG UniProtKB/TrEMBL DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	18	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Merck Research Laboratories Curated by ChEMBL					Assay Description Inhibition of Hepatitis C virus (isolate BK) genotype 1b NS3/4a protease A156T mutant expressed in Escherichia coli by time-resolved fluorescence ana...				ACS Med Chem Lett 3: 332-6 (2012) Article DOI: 10.1021/ml300017p BindingDB Entry DOI: 10.7270/Q2KH0R6V
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM322581 (US10183940, Example 33) Show SMILES Cc1cccc2c(n[nH]c12)C(C)(C)NC(=O)c1cccc2CNCCOc12 Show InChI InChI=1S/C21H24N4O2/c1-13-6-4-8-15-17(13)24-25-19(15)21(2,3)23-20(26)16-9-5-7-14-12-22-10-11-27-18(14)16/h4-9,22H,10-12H2,1-3H3,(H,23,26)(H,24,25)	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	21.7	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description Method description for binding assays with human Somatostatin receptors by use of CHO cell membranes expressing recombinant human SSTR1 or human SSTR...				US Patent US10183940 (2019) BindingDB Entry DOI: 10.7270/Q2KW5J45
					More data for this Ligand-Target Pair
Genome polyprotein (Hepacivirus C)	BDBM50326055 ((1R,21S,24S)-21-tert-Butyl-N-((1R,2R)-1-{[(cyclopr...) Show SMILES CC(C)(C)[C@@H]1NC(=O)OCC(C)(C)CCCCc2cccc3CN(Cc23)C(=O)O[C@@H]2C[C@H](N(C2)C1=O)C(=O)N[C@@]1(C[C@H]1C=C)C(=O)NS(=O)(=O)C1CC1 |r| Show InChI InChI=1S/C38H53N5O9S/c1-7-25-18-38(25,33(46)41-53(49,50)27-14-15-27)40-31(44)29-17-26-20-43(29)32(45)30(36(2,3)4)39-34(47)51-22-37(5,6)16-9-8-11-23-12-10-13-24-19-42(21-28(23)24)35(48)52-26/h7,10,12-13,25-27,29-30H,1,8-9,11,14-22H2,2-6H3,(H,39,47)(H,40,44)(H,41,46)/t25-,26-,29+,30-,38-/m1/s1	PDB Reactome pathway KEGG UniProtKB/TrEMBL DrugBank GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	22	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Merck Research Laboratories Curated by ChEMBL					Assay Description Inhibition of Hepatitis C virus (isolate BK) genotype 1b NS3/4a protease A156T mutant expressed in Escherichia coli by time-resolved fluorescence ana...				ACS Med Chem Lett 3: 332-6 (2012) Article DOI: 10.1021/ml300017p BindingDB Entry DOI: 10.7270/Q2KH0R6V
					More data for this Ligand-Target Pair
Genome polyprotein (Hepacivirus C)	BDBM50485493 (CHEMBL2063086) Show SMILES [H][C@@]12C[C@H](N(C1)C(=O)[C@@H](NC(=O)OCC(C)(C)CCCCCc1nc3ccccc3cc1O2)C1CCCCC1)C(=O)N[C@@]1(C[C@H]1C=C)C(=O)NS(=O)(=O)C1CC1 |r| Show InChI InChI=1S/C41H55N5O8S/c1-4-28-23-41(28,38(49)45-55(51,52)30-18-19-30)44-36(47)33-22-29-24-46(33)37(48)35(26-13-7-5-8-14-26)43-39(50)53-25-40(2,3)20-12-6-9-17-32-34(54-29)21-27-15-10-11-16-31(27)42-32/h4,10-11,15-16,21,26,28-30,33,35H,1,5-9,12-14,17-20,22-25H2,2-3H3,(H,43,50)(H,44,47)(H,45,49)/t28-,29-,33+,35+,41-/m1/s1	PDB Reactome pathway KEGG UniProtKB/TrEMBL DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	27	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Merck Research Laboratories Curated by ChEMBL					Assay Description Inhibition of Hepatitis C virus (isolate BK) genotype 1b NS3/4a protease A156T mutant expressed in Escherichia coli by time-resolved fluorescence ana...				ACS Med Chem Lett 3: 332-6 (2012) Article DOI: 10.1021/ml300017p BindingDB Entry DOI: 10.7270/Q2KH0R6V
					More data for this Ligand-Target Pair
Genome polyprotein (Hepacivirus C)	BDBM50485489 (CHEMBL1672609 | MK-1220) Show SMILES [H][C@@]12C[C@H](N(C1)C(=O)[C@@H](NC(=O)OCC(C)(C)CCCc1cc3c(O2)nccc3cc1OC)C1CCCCC1)C(=O)N[C@@]1(C[C@H]1C=C)C(=O)NS(=O)(=O)C1CC1 |r| Show InChI InChI=1S/C40H53N5O9S/c1-5-27-21-40(27,37(48)44-55(50,51)29-13-14-29)43-34(46)31-20-28-22-45(31)36(47)33(24-10-7-6-8-11-24)42-38(49)53-23-39(2,3)16-9-12-26-18-30-25(19-32(26)52-4)15-17-41-35(30)54-28/h5,15,17-19,24,27-29,31,33H,1,6-14,16,20-23H2,2-4H3,(H,42,49)(H,43,46)(H,44,48)/t27-,28-,31+,33+,40-/m1/s1	PDB Reactome pathway KEGG UniProtKB/TrEMBL DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	27	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Merck Research Laboratories Curated by ChEMBL					Assay Description Inhibition of Hepatitis C virus (isolate BK) genotype 1b NS3/4a protease D168V mutant expressed in Escherichia coli by time-resolved fluorescence ana...				ACS Med Chem Lett 3: 332-6 (2012) Article DOI: 10.1021/ml300017p BindingDB Entry DOI: 10.7270/Q2KH0R6V
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM322587 (US10183940, Example 39) Show SMILES Cn1nc(c2cccc(F)c12)C(C)(C)NC(=O)c1cccc2CNCCOc12 Show InChI InChI=1S/C21H23FN4O2/c1-21(2,19-14-7-5-9-16(22)17(14)26(3)25-19)24-20(27)15-8-4-6-13-12-23-10-11-28-18(13)15/h4-9,23H,10-12H2,1-3H3,(H,24,27)	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	29.1	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description Method description for binding assays with human Somatostatin receptors by use of CHO cell membranes expressing recombinant human SSTR1 or human SSTR...				US Patent US10183940 (2019) BindingDB Entry DOI: 10.7270/Q2KW5J45
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM312012 (US10166214, Example 148 | US10675268, Example 148 ...) Show SMILES Cc1nc(c2cccc(C)c2n1)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12 |r| Show InChI InChI=1S/C19H24N4O/c1-10-6-5-7-12-16(10)21-11(2)22-17(12)19(3,4)23-18(24)15-13-8-20-9-14(13)15/h5-7,13-15,20H,8-9H2,1-4H3,(H,23,24)/t13-,14+,15+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	32.3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...				US Patent US10166214 (2019) BindingDB Entry DOI: 10.7270/Q2D50Q16
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM312012 (US10166214, Example 148 | US10675268, Example 148 ...) Show SMILES Cc1nc(c2cccc(C)c2n1)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12 |r| Show InChI InChI=1S/C19H24N4O/c1-10-6-5-7-12-16(10)21-11(2)22-17(12)19(3,4)23-18(24)15-13-8-20-9-14(13)15/h5-7,13-15,20H,8-9H2,1-4H3,(H,23,24)/t13-,14+,15+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	32.3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description Receptor binding assays refer to a technique in which labeled receptor ligands are used to detect binding to a receptor. In competition experiments t...				US Patent US9789082 (2017) BindingDB Entry DOI: 10.7270/Q2CN760Q
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM312012 (US10166214, Example 148 | US10675268, Example 148 ...) Show SMILES Cc1nc(c2cccc(C)c2n1)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12 |r| Show InChI InChI=1S/C19H24N4O/c1-10-6-5-7-12-16(10)21-11(2)22-17(12)19(3,4)23-18(24)15-13-8-20-9-14(13)15/h5-7,13-15,20H,8-9H2,1-4H3,(H,23,24)/t13-,14+,15+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	32.3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description Receptor binding assays refer to a technique in which labeled receptor ligands are used to detect binding to a receptor. In competition experiments t...				US Patent US10675268 (2020) BindingDB Entry DOI: 10.7270/Q21C20XK
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311904 (US10166214, Example 40 | US10675268, Example 40 | ...) Show SMILES Cc1ccccc1OCC(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12 |r| Show InChI InChI=1S/C17H24N2O2/c1-11-6-4-5-7-14(11)21-10-17(2,3)19-16(20)15-12-8-18-9-13(12)15/h4-7,12-13,15,18H,8-10H2,1-3H3,(H,19,20)/t12-,13+,15+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	37.1	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description Receptor binding assays refer to a technique in which labeled receptor ligands are used to detect binding to a receptor. In competition experiments t...				US Patent US9789082 (2017) BindingDB Entry DOI: 10.7270/Q2CN760Q
					More data for this Ligand-Target Pair

Displayed 1 to 50 (of 2287 total )  |  Next  |  Last  >>

Jump to: